RAPP
insider transactionsRapport Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-915.3K
0 buy · 915.3K sell
Net value · 90d
-$36.5M
$0 in · $36.5M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
13
0 buy · 915.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Grant·A
Director
$0
15.2K sh
Own New
-
Sell·S
10% Owner · 10b5-1
$743.8K
18.6K sh · $40.05
Own -0%
-
Sell·S
10% Owner · 10b5-1
$5.4M
133.6K sh · $40.24
Own -2%
-
Sell·S
10% Owner · 10b5-1
$202.3K
5.0K sh · $40.31
Own -0%
-
Sell·S
10% Owner · 10b5-1
$10.9M
271.5K sh · $40.12
Own -4%
-
Exercise·C
Director
$0
210.5K sh
Own New
-
Exercise·C
Director
—
67.0K sh
Own +8%
-
Exercise·C
Director
$0
2.5M sh
Own New
-
Exercise·C
Director
$0
6.1M sh
Own New
-
Exercise·C
Director
—
804.4K sh
Own +42%
-
Exercise·C
Director
—
1.9M sh
Own New
-
Grant·A
Director
$0
991.2K sh
Own New
-
Grant·A
Director
$0
12.3K sh
Own New
-
Sell·S
10% Owner · 10b5-1
$17.2M
426.0K sh · $40.32
Own -6%
-
Sell·S
Chief Development Officer · 10b5-1
$808.8K
20.2K sh · $39.99
Own -8%
-
Sell·S
Chief Development Officer · 10b5-1
$357.8K
10.2K sh · $35.08
Own -4%
-
Sell·S
Chief Development Officer · 10b5-1
$320.5K
9.2K sh · $34.97
Own -3%
-
Sell·S
Chief Development Officer · 10b5-1
$17.5K
500 sh · $34.98
Own -0%
-
Sell·S
Chief Development Officer · 10b5-1
$12.6K
360 sh · $34.90
Own -0%
-
Sell·S
Chief Operating Officer · 10b5-1
$81.1K
2.8K sh · $28.55
Own -2%
-
Sell·S
Chief Operating Officer · 10b5-1
$200.8K
7.2K sh · $28.04
Own -4%
-
Sell·S
Chief Development Officer · 10b5-1
$303.4K
10.1K sh · $29.99
Own -3%
About RAPP insider trading
This page tracks insider transactions for Rapport Therapeutics, Inc. (RAPP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.